Can Wegovy Cause Hot Flashes — and What Should You Do About It?

Step 1: Check the official side-effect list first

The first thing worth doing takes under a minute: read the side-effects section of the Wegovy Patient Information Leaflet that came with your pen. Hot flashes (sometimes called hot flushes) do not appear there as a listed common or uncommon reaction. The recognised side effects are led by gastrointestinal symptoms (nausea, diarrhoea, constipation and related discomfort) alongside fatigue, headache and, less often, injection-site reactions. Our Wegovy overview covers the full picture, but for the authoritative list the NHS semaglutide medicines page is the right starting point. Finding that hot flashes are not on the official list does not mean your experience is imaginary; it means the cause almost certainly lies elsewhere.

Semaglutide works by activating GLP-1 receptors that regulate appetite and slow gastric emptying. That mechanism has no direct pathway to the hypothalamic thermoregulatory system that drives hot flashes. So if you are experiencing them, the medicine is probably not the direct cause.

Step 2: Understand what is actually driving the flashes

The more likely explanation sits in what the medicine is doing rather than in the molecule itself. Significant, sustained weight loss changes the hormonal landscape fairly quickly. Oestrogen is synthesised and stored partly in adipose tissue; as fat mass falls, the body's oestrogen reservoir shifts, and in women approaching or past menopause this disruption can be enough to trigger or intensify vasomotor symptoms. The same mechanism is seen with any effective weight-loss intervention (surgical or pharmacological) not with Wegovy specifically.

There is also a practical angle. Many people starting semaglutide for weight management are women in their forties and fifties, an age group where perimenopausal hot flashes may already be present or about to emerge. Separating a coincidental menopausal symptom from a treatment-related one is genuinely difficult without a prescriber's input. If you were having occasional night sweats before starting, the reduction in food intake and body fat during treatment may simply make them more noticeable.

Dehydration can also play a role. Nausea and reduced appetite early in treatment sometimes lead to lower fluid intake, and mild dehydration is a known trigger for flushing sensations. A practical check: note whether the flushes cluster in the days immediately after each weekly injection (the period when GI side effects tend to peak) which would point towards dehydration rather than a hormonal shift. If that pattern holds, increasing water intake around injection day is a reasonable starting point to discuss with your prescriber.

Step 3: Know when to raise it and what to mention

Hot flashes that are mild and occasional rarely need urgent attention, but they are worth mentioning at your next clinical review. Your prescriber can help distinguish between vasomotor symptoms driven by weight change, emerging menopause, or something unrelated to Wegovy entirely. A closer look at hot flashes specifically compared with other Wegovy flushing reactions is a useful read alongside this page.

If hot flashes are severe, disturbing sleep most nights, or accompanied by chest tightness, palpitations or shortness of breath, contact your prescriber or GP promptly rather than waiting. Those accompanying symptoms need ruling out, even if the likely explanation is still hormonal. Worth checking: the Wegovy leaflet also lists the signs of more serious reactions that warrant stopping treatment and seeking urgent help, allergic reactions, gallbladder symptoms and, following an MHRA Drug Safety Update in early 2026, severe persistent stomach pain that may indicate pancreatitis. Hot flashes alone do not fall into that category, but any new symptom during treatment deserves an accurate assessment.

Women on oral HRT who are also taking Wegovy should discuss their contraception and HRT arrangements with their prescriber, since gut-motility changes can theoretically affect absorption of oral preparations. NHS England specifically recommends transdermal options for tirzepatide; it is reasonable to have the same conversation about semaglutide, and our page on other vasomotor and circulatory questions touches on related considerations. If you are exploring how hot flashes compare to the broader spectrum of reported reactions, this overview of documented effects is a good companion. For skin-related reactions specifically, our rash page covers the distinction between injection-site irritation and systemic reactions.

Step 4: Factor this into whether Wegovy is right for you

For most people, hot flashes during Wegovy treatment are a manageable, temporary feature of a body adjusting to meaningful weight loss, not a sign the medicine is harming them. If you are considering starting treatment and menopausal symptoms are already part of your picture, being upfront about that during your consultation allows the prescriber to account for it from the beginning. That is exactly the kind of nuance a clinical assessment exists to capture.

Questions about digestive side effects are among the most common ones our prescribers hear, and vasomotor symptoms increasingly come up alongside them as more people in the peri- and postmenopausal age range start treatment. Understanding the cost and access side of things is also worth a look: our Wegovy cost guide explains what private treatment actually includes. If you would like to talk through your specific situation, checking your eligibility with our prescribers is the place to start, the consultation is free and reviewed by a real clinician the same day.